ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Obituary: Eugene Schonfeld, Founder of Kidney Cancer Foundation

October 3, 1997

Lurie Center At Northwestern Wins Core Grant Renewal.

December 7, 2001

NCI Begins TAILORx Study.

May 26, 2006

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

January 29, 2010

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010